share_log

Kovo HealthTech Announces Results of Its 2023 Annual General and Special Meeting of Shareholders

Kovo HealthTech Announces Results of Its 2023 Annual General and Special Meeting of Shareholders

Kovo HealthTech公布其2023年年度股东大会和特别股东大会的结果
newsfile ·  2023/12/11 17:15

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2023) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" "Kovo") a leader in healthcare technology and Billing-as-a-Service — is pleased to announce the results of its 2023 Annual General and Special Meeting ("the Meeting") of Shareholders, which was held on December 8, 2023.

不列颠哥伦比亚省温哥华--(Newsfile Corp.,2023年12月11日)——医疗保健技术和计费即服务领域的领导者Kovo HealthTech Corporation(多伦多证券交易所股票代码:KOVO)(“公司” “Kovo”)欣然宣布其于2023年12月8日举行的2023年年度股东大会和特别股东大会(“大会”)的结果。

Shareholders unanimously re-elected Kovo's Board of Directors nominees, appointed SRCO Professional Corporation, Chartered Accountants as the Company's auditor — and voted to set the Company's Board of Directors at four. Shareholders also approved proposed amendments to the Company's Equity Incentive Plan as described and pre-circulated in the Company's management information circular dated November 2, 2023.

股东们一致再次选举了Kovo的董事会候选人,任命SRCO专业公司、特许会计师事务所为公司的审计师,并投票决定将公司的董事会人数定为四人。股东们还批准了公司股权激励计划的拟议修正案,该修正案已在公司2023年11月2日的管理信息通告中描述和预先分发。

Meeting Results

会议结果

The detailed results of the Meeting were as follows:

会议的详细结果如下:

Number of Directors

董事人数

Management's proposal to set the number of Directors at four (4) was approved by a majority of the votes cast by shareholders present or represented by proxy at the Meeting as follows:

管理层关于将董事人数定为四(4)人的提议已由出席会议或代理人代表的股东的多数票通过,具体如下:

Number of Directors Votes For % of Votes For % of Votes Against
Set at 4 38,729,374 96.24% 3.76%
董事人数 投赞成票 赞成票的百分比 百分比的反对票
设定为 4 38,729,374 96.24% 3.76%

Election of Directors

董事选举

The four (4) nominees for Director that were proposed by management of the Company were elected by a majority of the votes cast by shareholders present or represented by proxy at the Meeting. The votes cast for each nominee were as follows:

公司管理层提出的四(4)名董事候选人由出席会议或由代理人代表的股东以多数票选出。每位被提名人的选票如下:

Director Nominees Votes For % of Votes For % of Votes Against
Dr. Peter Bak 38,729,374 96.24% 3.76%
Harp Gahunia 38,729,374 96.24% 3.76%
Michael Steele 40,242,027 100% 0
Greg Noble 38,729,374 96.24% 3.76%
董事候选人 投赞成票 赞成票的百分比 百分比的反对票
彼得·巴克博士 38,729,374 96.24% 3.76%
Harp Gahunia 38,729,374 96.24% 3.76%
迈克尔·斯蒂尔 40,242,027 100% 0
格雷格诺布尔 38,729,374 96.24% 3.76%

Appointment of Auditor

任命审计员

SRCO Professional Corporation, Chartered Accountants, was appointed as the Company's auditor by a majority of the votes cast by shareholders present or represented by proxy at the Meeting, and Directors were authorized to fix the auditors' compensation. The votes were cast as follows:

SRCO Professional Corporation Corporation(特许会计师事务所)以出席会议或代理人代表的股东的多数票被任命为公司的审计师,董事有权确定审计师的薪酬。投票情况如下:

Auditor Votes For % of Votes For % Votes Against
SRCO Professional Corporation, Chartered Accountants 38,729,374 96.24% 3.76%
审计师 投赞成票 赞成票的百分比 % 反对票
SRCO 专业公司,特许会计师 38,729,374 96.24% 3.76%

Amendments to the Company's Equity Incentive Plan

对公司股权激励计划的修订

Management's proposed amendments to the Company's Equity Incentive Plan as described in the Company's management information circular dated November 2, 2023 was approved by a majority of votes cast by shareholders present or represented by proxy at the Meeting. The votes were cast as follows:

如公司2023年11月2日的管理信息通告中所述,管理层对公司股权激励计划的拟议修正案已获得出席会议或由代理人代表的股东的多数票批准。投票情况如下:

Votes For % of Votes For % of Votes Against
38,729,374 96.24% 3.76%
投赞成票 赞成票的百分比 百分比的反对票
38,729,374 96.24% 3.76%

Further details and related Meeting documents are available at

更多详情和相关会议文件可在以下网址查阅

About Kovo HealthTech Corporation

关于 Kovo 健康科技公司

Kovo HealthTech Corporation is a growing healthcare technology company that specializes in Billing-as-a-Service offering SaaS-style recurring revenue contracts and software for more than 2250 US healthcare providers. Kovo helps healthcare providers digitally track and manage complex patient care registration, services, billing and payments in a seamless way, using its industry-leading KovoCloud technology platform. Currently, through its clients, Kovo processes over USD$250 million in annual billing transactions for more than 4.5 million patients. By offering effective billing practices and technology through long-term SaaS-style contracts, Kovo helps healthcare practitioners get paid so they can focus on offering quality care. To learn more about Kovo and to keep up-to-date on Kovo news, visit

Kovo HealthTech Corporation是一家成长中的医疗保健科技公司,专门从事计费即服务,为2250多家美国医疗保健提供商提供SaaS式的经常性收入合同和软件。Kovo 使用其行业领先的 KovoCloud 技术平台,帮助医疗保健提供商以无缝方式数字化跟踪和管理复杂的患者护理登记、服务、账单和付款。目前,Kovo通过其客户每年为超过450万名患者处理超过2.5亿美元的账单交易。通过长期的SaaS式合同提供有效的计费做法和技术,Kovo帮助医疗保健从业者获得报酬,使他们能够专注于提供优质的护理。要了解有关 Kovo 的更多信息并了解最新的 Kovo 新闻,请访问

For more information:

欲了解更多信息:

Greg Noble, CEO
investors@kovo.co
1-866-558-6777

首席执行官格雷格·诺布尔
investors@kovo.co
1-866-558-6777

Forward-Looking Information and Non-IFRS Measures Statement

前瞻性信息和非国际财务报告准则指标声明

This press release may contain "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") concerning the Company and its subsidiaries within the meaning of applicable securities laws. Forward-looking information may relate to the future financial outlook and anticipated events or results of the Company and may include information regarding the Company's financial position, business strategy, growth strategies, acquisition prospects and plans, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly, information regarding the Company's expectations of future results, performance, achievements, prospects or opportunities or the markets in which the Company operates is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects", "budgets", "scheduled", "estimates", "outlook", "forecasts", "projects", "prospects", "strategy", "intends", "anticipates", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", or "will" occur. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances. Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking information, including, without limitation, those listed in the "Risk Factors" section of the final prospectus of the Company dated May 26, 2021. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements could vary materially from those expressed or implied by the forward-looking statements contained in this press release. Forward-looking information, by its nature, is based on the Company's opinions, estimates and assumptions in light of management's experience and perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate and reasonable in the circumstances. Those factors should not be construed as exhaustive. Despite a careful process to prepare and review forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. These factors should be considered carefully, and readers should not place undue reliance on the forward-looking information. Although the Company bases its forward-looking information on assumptions that it believes were reasonable when made, which include, but are not limited to, assumptions with respect to the Company's future growth potential, results of operations, future prospects and opportunities, execution of the Company's business strategy, there being no material variations in the current tax and regulatory environments, future levels of indebtedness and current economic conditions remaining unchanged, the Company cautions readers that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which the Company operates may differ materially from the forward-looking statements contained in this press release. In addition, even if the Company's results of operations, financial condition and liquidity, and the development of the industry in which it operates are consistent with the forward-looking information contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date made (or as of the date they are otherwise stated to be made). Any forward-looking statement that is made in this press release speaks only as of the date of such statement.

本新闻稿可能包含适用证券法所指的有关公司及其子公司的 “前瞻性信息” 和 “前瞻性陈述”(统称为 “前瞻性信息”)。前瞻性信息可能与公司的未来财务前景和预期事件或业绩有关,可能包括有关公司财务状况、业务战略、增长战略、收购前景和计划、潜在市场、预算、运营、财务业绩、税收、股息政策、计划和目标的信息。特别是,有关公司对未来业绩、业绩、成就、前景或机遇或公司运营所在市场的预期的信息是前瞻性信息。在某些情况下,可以通过使用前瞻性术语来识别前瞻性信息,例如 “计划”、“目标”、“预期”、“预期”、“估计”、“展望”、“预测”、“项目”、“前景”、“战略”、“打算”、“预期”、“相信”,或某些行动、事件或结果 “可能” 的词语和短语或陈述的变体,“可能”、“会”、“可能” 或 “将” 发生。此外,任何涉及对未来事件或情况的预期、意图、预测或其他描述的陈述都包含前瞻性信息。包含前瞻性信息的陈述不是历史事实,而是代表管理层对未来事件或情况的预期、估计和预测。许多因素可能导致公司的实际业绩、业绩或成就与此类前瞻性信息可能表达或暗示的任何未来业绩、业绩或成就存在重大差异,包括但不限于2021年5月26日公司最终招股说明书 “风险因素” 部分中列出的业绩、业绩或成就。如果其中一项或多项风险或不确定性得以实现,或者如果前瞻性陈述所依据的假设被证明不正确,则实际结果、业绩或成就可能与本新闻稿中包含的前瞻性陈述所表达或暗示的结果存在重大差异。就其性质而言,前瞻性信息基于公司根据管理层的经验和对历史趋势、当前状况和未来预期发展的看法,以及公司目前认为在这种情况下适当和合理的其他因素而得出的观点、估计和假设。不应将这些因素解释为详尽无遗。尽管在准备和审查前瞻性信息方面采取了谨慎的程序,但无法保证基本观点、估计和假设会被证明是正确的。应仔细考虑这些因素,读者不应过分依赖前瞻性信息。尽管公司的前瞻性信息基于其认为合理的假设,包括但不限于对公司未来增长潜力、经营业绩、未来前景和机遇、公司业务战略执行、当前税收和监管环境没有重大变化、未来负债水平和当前经济状况保持不变的假设,但公司提醒读者,前瞻性陈述并非如此对未来业绩的担保,以及我们的实际经营业绩、财务状况和流动性以及公司运营所在行业的发展可能与本新闻稿中包含的前瞻性陈述存在重大差异。此外,即使公司的经营业绩、财务状况和流动性以及其运营所在行业的发展与本新闻稿中包含的前瞻性信息一致,但这些业绩或事态发展可能并不代表后续时期的业绩或发展。除非法律要求,否则公司没有义务公开更新或修改任何前瞻性陈述,无论是由于新信息、未来事件还是其他原因。尽管公司试图确定可能导致实际业绩与前瞻性信息中包含的结果存在重大差异的重要风险因素,但可能还有其他风险因素公司目前尚不为人所知,或者公司目前认为这些风险因素不重要,也可能导致实际业绩或未来事件与此类前瞻性信息中表达的结果存在重大差异。无法保证此类信息会被证明是准确的,因为实际结果和未来事件可能与此类信息中的预期存在重大差异。因此,读者不应过分依赖前瞻性信息,这些信息仅代表截至发布日期(或以其他方式声明发布之日)为准。本新闻稿中发表的任何前瞻性陈述仅代表截至该声明发布之日。

This press release may make reference to certain non-IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. The Company's definitions of non-IFRS measures used in this release may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses non-IFRS financial measures, including "ARR**", "EBITDA", "Adjusted EBITDA*" and "Adjusted EBITDA Margin" to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. "EBITDA" means net income (loss) before amortization and depreciation expenses, finance and interest costs, and provision for income taxes. *"Adjusted EBITDA" adjusts EBITDA for stock-based compensation expense, transactional gains or losses on assets, asset impairment charges, interest income, net foreign exchange gains or losses, income tax expense or recovery, forgivable one-time government financial payments related to the COVID-19 pandemic ("PPP Loans"), and any transactional expenses. Specifically, the Company believes that Adjusted EBITDA, when viewed with the Company's results under IFRS and the accompanying reconciliations, provides useful information about the Company's business without regard to potential distortions. By eliminating potential differences in results of operations between periods caused by factors such as depreciation and amortization methods and restructuring, impairment and other charges, the Company believes that Adjusted EBITDA can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated. The term Annual Recurring Revenue ("ARR") is a non-IFRS measure and refers to multiplying the monthly revenue for a current month by twelve. ARR is a metric typically used by recurring revenue companies to communicate run rate at a specific moment in time The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company's management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.

本新闻稿可能提及某些非国际财务报告准则指标。这些衡量标准不是《国际财务报告准则》认可的衡量标准,没有国际财务报告准则规定的标准含义,因此不太可能与其他公司提出的类似衡量标准相提并论。相反,这些衡量标准是作为补充信息提供的,目的是从管理层的角度进一步了解公司的经营业绩,从而补充这些国际财务报告准则指标。本公司对本新闻稿中使用的非国际财务报告准则指标的定义可能与其他公司在报告中使用的此类指标的定义不同。非国际财务报告准则指标作为分析工具存在局限性,不应孤立地考虑,也不能替代对根据国际财务报告准则报告的公司财务信息的分析。公司使用非国际财务报告准则财务指标,包括 “年度利率**”、“息税折旧摊销前利润”、“调整后息税折旧摊销前利润率*” 和 “调整后息税折旧摊销前利润率”,为投资者提供其经营业绩的补充指标,剔除对经营业绩或经营状况影响较小的项目,从而突出其核心业务的趋势,而这些趋势在仅依靠国际财务报告准则财务指标时可能不明显。“息税折旧摊销前利润” 是指扣除摊销和折旧费用、财务和利息成本以及所得税准备金前的净收益(亏损)。* “调整后息税折旧摊销前利润” 根据股票薪酬支出、资产交易损益、资产减值费用、利息收入、净外汇损益、所得税支出或回收、与 COVID-19 疫情相关的可免除的一次性政府财政付款(“PPP 贷款”)以及任何交易费用调整息税折旧摊销前利润。具体而言,公司认为,调整后的息税折旧摊销前利润与公司在国际财务报告准则下的业绩以及随之而来的对账相比,可以提供有关公司业务的有用信息,而不考虑潜在的扭曲情况。通过消除折旧和摊销方法以及重组、减值和其他费用等因素造成的不同时期经营业绩的潜在差异,公司认为,调整后的息税折旧摊销前利润可以为比较正在评估的标的业务的当前表现提供有用的额外依据。年度经常性收入(“ARR”)一词是非国际财务报告准则的衡量标准,是指将当月的月收入乘以十二。ARR是经常性收入公司通常用来传达特定时刻运行率的指标。公司认为,证券分析师、投资者和其他利益相关方在评估发行人时经常使用非国际财务报告准则财务指标。公司管理层还使用非国际财务报告准则财务指标,以促进不同时期的经营业绩比较。

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所风险交易所及其监管服务提供商(该术语在多伦多证券交易所风险交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任

To view the source version of this press release, please visit

要查看本新闻稿的源版本,请访问

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发